Medical
The drugmaker that hopes to legalize MDMA is cutting 75% of its staff after the FDA rejected the drug
Lykos will cut 75% of its staff, or about 100 employees, and the remaining team will focus on working with the FDA, the company said.
![The drugmaker that hopes to legalize MDMA is cutting 75% of its staff after the FDA rejected the drug](https://phuketnews.easybranches.com/uploads/news/2024/08/12091406.jpg)
- Lykos Therapeutics is cutting 75% of staff after FDA rejected its MDMA drug for mental health.
- The FDA's decision ma… [+1998 chars]
Related